FORT WASHINGTON INVESTMENT ADVISORS INC /OH/
Position in BMY — Bristol Myers Squibb Co
CIK 1009016
Cincinnati, OH
Position in BMY
as of Mar 31, 2026
· filed Apr 22, 2026
Position Value
$158,049,472
+$10,995,008 QoQ
Shares Held
2,605,927
-4.4% QoQ
Ownership
0.128%
of shares outstanding
% of Portfolio
1.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 93.21162521893032.ToString("F0")%
Shared 0.ToString("F0")%
None 6.7883747810696855.ToString("F0")%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ holds $685,312,998 across 9 Drug Manufacturers - General names. BMY ranks #2 (23.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
1,064,304 | $260,158,469 | |
| 2 | BMY |
Bristol Myers Squibb Co
This page
|
2,605,927 | $158,049,472 | |
| 3 | MRK |
Merck & Co., Inc.
|
659,851 | $79,373,476 | |
| 4 | PFE |
Pfizer Inc
|
2,042,039 | $57,340,455 | |
| 5 | LLY |
ELI LILLY & Co
|
52,225 | $48,034,988 | |
| 6 | ABBV |
AbbVie Inc.
|
207,858 | $45,207,035 | |
| 7 | AMGN |
Amgen Inc
|
92,090 | $32,401,865 | |
| 8 | NVS |
Novartis AG
|
29,042 | $4,436,165 |
All Filings in BMY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $158,049,472 | 2,605,927 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $147,054,464 | 2,726,260 | Shares | Sole | 2026-01-13 | |
| 2025-09-30 | $121,161,646 | 2,686,511 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $120,330,484 | 2,599,492 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $158,110,293 | 2,592,397 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $145,558,347 | 2,573,521 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $132,224,053 | 2,555,548 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $105,879,696 | 2,549,475 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $138,912,476 | 2,561,543 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $130,472,452 | 2,542,827 | Shares | Defined | 2024-01-17 | |
| 2023-09-30 | $116,115,810 | 2,000,617 | Shares | Defined | 2023-11-07 | |
| 2023-06-30 | $129,235,531 | 2,020,884 | Shares | Defined | 2023-07-28 | |
| 2023-03-31 | $141,501,424 | 2,041,573 | Shares | Defined | 2023-04-28 | |
| 2022-12-31 | $148,095,188 | 2,058,307 | Shares | Defined | 2023-01-30 | |
| 2022-09-30 | $179,001,704 | 2,517,959 | Shares | Defined | 2022-10-26 | |
| 2022-06-30 | $227,789,254 | 2,958,302 | Shares | Defined | 2022-08-05 | |
| 2022-03-31 | $321,820,278 | 4,406,686 | Shares | Defined | 2022-05-03 | |
| 2021-12-31 | $276,532,350 | 4,435,162 | Shares | Defined | 2022-02-07 | |
| 2021-09-30 | $219,404,904 | 3,708,043 | Shares | Defined | 2021-11-09 | |
| 2021-06-30 | $136,245,578 | 2,038,994 | Shares | Defined | 2021-08-09 | |
| 2021-03-31 | $126,175,026 | 1,998,654 | Shares | Defined | 2021-05-05 | |
| 2020-12-31 | $118,183,401 | 1,905,262 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $123,662,928 | 2,051,135 | Shares | Defined | 2020-11-10 | |
| 2020-06-30 | $114,091,873 | 1,940,338 | Shares | Defined | 2020-07-31 | |
| 2020-03-31 | $108,179,411 | 1,940,786 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||